Ann: Imugene Receives PD1-VAXX Ethics Trial Approval in USA, page-131

First 131 Last

Share
Profile

Follow
Ianwil

13,345 Posts.

953

11/09/20

17:29

Post #: 47278571
Share

Originally posted by Steini ↑

"Does it mean Her-Vaxx is equal or better than any of the chemo out there? this is mind blogging!!!"

MrK, in an interview in November 2019 one of IMU's directors, Axel Hoos, confirmed already that Her-Vaxx is functioning as designed, meaning safer and activating the immune system to fight the cancer. The vaxx works, what impacts the outcome and efficacy is the state of the immune system of a patient. A fully functioning immune system should have no problem to kill the cancer cells and prevent the re-occurrence. But the trial participants have been exposed to chemo during the first 84? days which has impacted the immune system. And I could imagine that a stage 4 patient's health is impacted in many other ways which could have a further impact on the immune system. But the desired outcome, the production of body own anti-bodies has been achieved. What t-cell vax have done artifically with some negative side effects and saftey concerns has been outperformed by Her-Vaxx with no noticeable side effects.

I assume that the current LT participants are off chemo and Her-Vaxx is demonstrating its power.

And the achieved results which have influenced the design of PD1-Vaxx have contributed to the clean submission process for PD1-Vaxx to the current stage which as outlined previously, have been totally ignored by the market.

A falling sp is annoying when bought at higher prices. But it is not related to the achievements. And anyone interested in IMU will be happy to get some cheaper ones, maybe even cheaper next week depending on some holders perspective and financial situation.

We all want a BRN run every day. One day IMU will get one like this. By then my aim is to have accumulated a lot more which is easier sub 5c then above 50c.

Yes, I have been furious about the oppie underwriting and still would have done it differently. But that doesn't change my overall view and talking to LC confirmed that.

GLTA

Expand

This looks very obvious that this share price is being held back for some reason or another, maybe big pharmer don't want us to be successful . A bit like oil and coal vs the future.

IMU Price at posting: 4.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 67 more messages in this thread...

First 131 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change 0.001(1.04%)		Mkt cap ! $364.4M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.8¢	$191.4K	3.938M

Buyers (Bids)

No.	Vol.	Price($)
70	7593725	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	2747514	26

View Market Depth

No.	Vol.	Price($)
70	7592646	0.048
48	4497673	0.047
59	3848487	0.046
64	7403753	0.045
14	2259852	0.044

Price($)	Vol.	No.
0.049	2747032	25
0.050	4576608	22
0.051	7009844	16
0.052	2608295	12
0.053	2041281	10

Last trade - 14.55pm 04/10/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Imugene Receives PD1-VAXX Ethics Trial Approval in USA, page-131

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Imugene Receives PD1-VAXX Ethics Trial Approval in USA, page-131

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News